115 related articles for article (PubMed ID: 11173150)
1. Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas.
Horii N; Nishimura Y; Okuno Y; Kanamori S; Hiraoka M; Shimada Y; Imamura M
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):527-32. PubMed ID: 11173150
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
[TBL] [Abstract][Full Text] [Related]
3. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
5. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.
Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K
Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Nakamura H; Hirata T; Kitamura H; Nishikawa J
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
[TBL] [Abstract][Full Text] [Related]
8. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy.
Hickey K; Grehan D; Reid IM; O'Briain S; Walsh TN; Hennessy TP
Cancer; 1994 Sep; 74(6):1693-8. PubMed ID: 7915963
[TBL] [Abstract][Full Text] [Related]
10. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of cell cycle markers in esophageal cancer after neoadjuvant chemotherapy.
Yasunaga M; Tabira Y; Kondo K; Okuma T; Kitamura N
Dis Esophagus; 1999; 12(2):120-7. PubMed ID: 10466044
[TBL] [Abstract][Full Text] [Related]
12. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study.
Takeuchi H; Kubota T; Kabuto M; Kitai R; Nozaki J; Yamashita J
Surg Neurol; 1997 Nov; 48(5):501-6. PubMed ID: 9352816
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected].
Beardsmore DM; Verbeke CS; Davies CL; Guillou PJ; Clark GW
J Gastrointest Surg; 2003 Jan; 7(1):77-86; discussion 86-7. PubMed ID: 12559188
[TBL] [Abstract][Full Text] [Related]
14. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
15. No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry.
Møller ML; Braendstrup O
J Neurooncol; 1997 Sep; 34(3):241-6. PubMed ID: 9258816
[TBL] [Abstract][Full Text] [Related]
16. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
[TBL] [Abstract][Full Text] [Related]
19. Methyl-methanesulfonate sensitivity 19 expression is associated with metastasis and chemoradiotherapy response in esophageal cancer.
Zhang JL; Wang HY; Yang Q; Lin SY; Luo GY; Zhang R; Xu GL
World J Gastroenterol; 2015 Apr; 21(14):4240-7. PubMed ID: 25892874
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of Ki 67 and PCNA expression in laryngeal squamous cell carcinoma (morphometric evaluation of labelling index-L1].
Woźniak A; Golusiński W; Kaczmarek E; Kaczmarek J; Kaczmarek J
Otolaryngol Pol; 2002; 56(4):437-43. PubMed ID: 12378803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]